← Back to Search

Povidone Iodine nasal swab for Skin Cancer

N/A

Waitlist Available

Led By Nahid Y. Vidal, M.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Able to swallow, retain, and absorb oral medications

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days after mms

Awards & highlights

Study Summary

This trial aims to compare the infection rates in patients who undergo Mohs micrographic surgery using two different approaches: one involves using a nasal swab with povidone iodine, and the other involves

Who is the study for?

This trial is for patients undergoing Mohs micrographic surgery, a procedure to remove skin cancer. Participants must meet certain health standards but specific inclusion and exclusion criteria are not detailed here.Check my eligibility

What is being tested?

The study compares infection rates after skin cancer surgery between two groups: one treated with nasal iodine swabs and the other with standard oral antibiotics.See study design

What are the potential side effects?

Possible side effects may include irritation or allergic reaction from the iodine swabs, and typical antibiotic-related issues like stomach upset or allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can take pills and my body can absorb them.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days after mms

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days after mms

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days after mms for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Effectiveness of nasal decolonization with povidone-iodine versus a standardized oral antibiotic prophylaxis protocol to prevent surgical site infection (SSI)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Povidone Iodine nasal swabExperimental Treatment2 Interventions

Patients undergoing Mohs micrographic surgery (MMS) for malignant cutaneous neoplasms will receive nasal povidone-iodine swabs prior to skin reconstruction.

Group II: Oral antibiotic prophylaxis protocol (usual care)Experimental Treatment2 Interventions

Patients undergoing Mohs micrographic surgery (MMS) for malignant cutaneous neoplasms will receive standard of care, including the provision of an oral anti-staphylococcal antibiotic per the standardized Antibiotic Prophylaxis protocol currently used for clinical decision making in Dermatologic Surgery at Mayo Clinic Rochester.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Antibiotic

2008

Completed Phase 4

~3070

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,227 Previous Clinical Trials

3,770,136 Total Patients Enrolled

Nahid Y. Vidal, M.D.Principal InvestigatorMayo Clinic in Rochester

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently able to participate in this ongoing research study?

"According to the information provided on clinicaltrials.gov, this specific medical trial is not currently actively seeking participants. The initial posting date was February 1st, 2024, and it was last updated on January 16th, 2024. However, it's worth noting that there are presently 232 other ongoing clinical trials that are actively recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery

2024. "Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06207786.